BNET Industries

Market Cap:$147.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
A Dividend-Stock Holiday Shopping List
-
Pfizer Whistleblower Named Year's Most Influential Person In Business Ethics
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Adimab Signs Deal with Pfizer
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
News & Analysis
Filter by
biotechnology and pfizer inc. - All News and Analysis
Pfizer Demands DNA of Trovan Victims Who Are Owed Compensation
Victims covered by Pfizer's $75 million settlement of the Trovan meningitis case in Nigeria must produce DNA tests before they will receive their part of the payout, according to This Day, an African news web site. by Jim Edwards
Pfizer to Close S.F. Biotech Center in Favor of Unit Accused in Patent Suit
Pfizer is pulling out of its much-heralded Biotherapeutics and Bioinnovation Center in San Francisco. The BBC is no longer relevant now that Pfizer has acquired Wyeth's big biotech assets. by Jim Edwards
Pfizer, Vertex Execs Are Victims of Facebook Faker; Forbes, WSJ Also Targeted
Someone is impersonating prominent members of the pharma and biotech world on Facebook, including Vertex Pharmaceuticals chief executive Joshua Boger, a chief science officer at Pfizer and Forbes drug writer Matt Herper. by Jim Edwards
Pfizer Biotech Chief Signs Vow of Silence for $1.7 Million
Corey Goodman, the guy hired to run Pfizer's "Bioinnovation Center" in San Francisco, signed an omertà -style vow upon leaving the company: He must never talk about Pfizer again, to anyone, ever, the agreement basically states. Pfizer, which had too many R&D chiefs following its decision to merge...
Pharma Roundup: Pfizer, Wyeth, Amgen, Bristol, and More
Pfizer and Wyeth: how many jobs are actually being cut? -- The Health Blog provides a run-down on the various figures that are being tossed around, from 18,000 to 26,000. Their estimate with the math to back it up is 19,425 from the combined company, with at least 8,190 coming...
Pharma Roundup: Pfizer and the Rat, Johnson & Johnson in Europe, and More
Pfizer's gruesome new anti-counterfeit campaign -- In the U.K., Pfizer has rolled out a new TV ad that warns consumers against the dangers of counterfeit drugs. The nauseating image of a man pulling a rat from his mouth intends to educate consumers about the dangerous substances like rat poison which...
Pharma Roundup: Merck Eyes Generics, Pfizer Delays Layoffs, and More
Merck launches generics business, Pfizer delays layoffs, Europe can continue to repackage drugs. by John Maas
Pharma Roundup: Sanofi and Pfizer Trim Obesity Drugs, Teva Challenges Merck Patent, and More
Sanofi, Pfizer cancel obesity drugs; Merck faces patent challenge from Teva; Medco CEO predicts 2009 legislation on biotech generics; contract research organizations hurting, too. by John Maas
Pharma Roundup: Pfizer Re-Slices Organizational Pie, Lilly Dishes Out Zyprexa Settlement, and More
Pfizer reorganizes; Lilly to pay $62 million fine over Zyprexa; biotech losing talent to clean tech; Consumer Reports blacklists 20 drugs for seniors by John Maas
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor® and founder of Esperion Therapeutics, Inc
CHARLOTTE, N.C. -- The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.com) taking place at the Barnhardt Student Activities Center on October 28, 2008. This flagship conference represents the region's top biotechnology thought leaders in research, investment, education,...
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

